These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15717052)

  • 1. The blood-brain barrier and neurotherapeutics.
    Pardridge WM
    NeuroRx; 2005 Jan; 2(1):1-2. PubMed ID: 15717052
    [No Abstract]   [Full Text] [Related]  

  • 2. The blood-brain barrier: bottleneck in brain drug development.
    Pardridge WM
    NeuroRx; 2005 Jan; 2(1):3-14. PubMed ID: 15717053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular definition of neuronal targets for novel neurotherapeutics: SNAREs and Kv1 channels.
    Dolly JO
    Neurotoxicology; 2005 Oct; 26(5):753-60. PubMed ID: 16125246
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." The blood-brain barrier: a physical and conceptual challenge.
    Hachinski V; Lee TY
    Alzheimers Dement; 2009 Sep; 5(5):435-6. PubMed ID: 19751924
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial: central nervous system drugs in the treatment of neurological disorders.
    Samsam M
    Cent Nerv Syst Agents Med Chem; 2012 Sep; 12(3):153-7. PubMed ID: 22894608
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of neuropeptide drugs that cross the blood-brain barrier.
    Egleton RD; Davis TP
    NeuroRx; 2005 Jan; 2(1):44-53. PubMed ID: 15717056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two Latest Hot Researches in Medicinal Chemistry.
    Zhou GP; Chou KC
    Curr Top Med Chem; 2020; 20(4):264-265. PubMed ID: 32238127
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood-brain barrier: an impediment to neuropharmaceuticals.
    Henderson JT; Piquette-Miller M
    Clin Pharmacol Ther; 2015 Apr; 97(4):308-13. PubMed ID: 25670372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Opening the brain to new therapies].
    Collin L
    Med Sci (Paris); 2014 May; 30(5):486-8. PubMed ID: 24939528
    [No Abstract]   [Full Text] [Related]  

  • 10. Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." Alzheimer's disease drugs: more than one barrier to breach.
    Roher AE; Kokjohn TA
    Alzheimers Dement; 2009 Sep; 5(5):437-8. PubMed ID: 19751925
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
    Löscher W; Potschka H
    Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational aspects of blood-brain barrier transport and central nervous system effects of drugs: from discovery to patients.
    de Lange EC; Hammarlund-Udenaes M
    Clin Pharmacol Ther; 2015 Apr; 97(4):380-94. PubMed ID: 25670219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-blood ratio: implications in brain drug delivery.
    Kulkarni AD; Patel HM; Surana SJ; Belgamwar VS; Pardeshi CV
    Expert Opin Drug Deliv; 2016; 13(1):85-92. PubMed ID: 26393289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The blood-brain barrier friend or foe?
    Scarpa M; Begley D
    J Inherit Metab Dis; 2013 May; 36(3):435-6. PubMed ID: 23620469
    [No Abstract]   [Full Text] [Related]  

  • 15. Structural modifications that alter the P-glycoprotein efflux properties of compounds.
    Hitchcock SA
    J Med Chem; 2012 Jun; 55(11):4877-95. PubMed ID: 22506484
    [No Abstract]   [Full Text] [Related]  

  • 16. [Neurological disorders and the blood-brain barrier. Strategies and limitations for drug delivery to the brain].
    Domínguez A; Álvarez A; Suárez-Merino B; Goñi-de-Cerio F
    Rev Neurol; 2014 Mar; 58(5):213-24. PubMed ID: 24570360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicinal chemical properties of successful central nervous system drugs.
    Pajouhesh H; Lenz GR
    NeuroRx; 2005 Oct; 2(4):541-53. PubMed ID: 16489364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Direct drug delivery to the brain].
    Chekhonin VP; Zhirkov IuA; Dmitrieva TB
    Vestn Ross Akad Med Nauk; 2006; (8):30-7. PubMed ID: 17002024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of blood-brain penetration using structural descriptors.
    Katritzky AR; Kuanar M; Slavov S; Dobchev DA; Fara DC; Karelson M; Acree WE; Solov'ev VP; Varnek A
    Bioorg Med Chem; 2006 Jul; 14(14):4888-917. PubMed ID: 16697202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The brain barriers as therapeutic targets in neuroinflammation.
    Engelhardt B
    Drug Res (Stuttg); 2013 Nov; 63 Suppl 1():S5. PubMed ID: 24242038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.